Good clinical study information….!

Novartis will fund a $20 million research center at the University of Pennsylvania in a deal in which the drugmaker gains technology that uses manipulated immune-system cells to fight cancer. Copy and paste the below into your browser for more information or contact us at info@racingtoregister.org

http://www.bloomberg.com/news/2012-08-06/novartis-gets-immune-cell-cancer-therapy-in-upenn-pact.html